Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SAfiledCriticalRoussel Uclaf SA
Priority to FR877900ApriorityCriticalpatent/FR1699M/fr
Priority to CH1282262Aprioritypatent/CH411856A/fr
Priority to ES282100Aprioritypatent/ES282100A1/es
Priority to GB41757/62Aprioritypatent/GB988803A/en
Application grantedgrantedCritical
Publication of FR1699MpublicationCriticalpatent/FR1699M/fr
C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07J—STEROIDS
C07J75/00—Processes for the preparation of steroids in general
Landscapes
Chemical & Material Sciences
(AREA)
Organic Chemistry
(AREA)
Health & Medical Sciences
(AREA)
General Health & Medical Sciences
(AREA)
Steroid Compounds
(AREA)
FR877900A1961-11-031961-11-03Nouveau médicament notamment pour le traitement des spasmes d'origine vasculaire et viscérale.
ActiveFR1699M
(fr)